Final analysis of the randomised, phase 3, COU-AA-302 study of abiraterone acetate (AA) in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract


Authors: De Souza, P.; Smith, M. R.; Fizazi, K.; Saad, F.; Mulders, P. F. A.; Sternberg, C. N.; Miller, K.; Logothetis, C. J.; Shore, N.; Small, E. J.; Carles, J.; Flaig, T. W.; Taplin, M. E.; Higano, C. S.; de Bono, J. S.; Griffin, T. W.; De Porre, P.; Yu, M. K.; Park, Y. C.; Li, J.; Kheoh, T.; Naini, V.; Molina, A.; Rathkopf, D. E.; Ryan, C. J.
Abstract Title: Final analysis of the randomised, phase 3, COU-AA-302 study of abiraterone acetate (AA) in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (mCRPC)
Meeting Title: 68th Urological Society of Australia and New Zealand (USANZ) Annual Scientific Meeting
Journal Title: BJU International
Volume: 115
Issue: Suppl. 4
Meeting Dates: 2015 Apr 11-14
Meeting Location: Adelaide, Australia
ISSN: 1464-4096
Publisher: Wiley Blackwell  
Date Published: 2015-04-01
Start Page: 21
End Page: 22
Language: English
ACCESSION: WOS:000351395100042
PROVIDER: wos
PUBMED: 25784371
DOI: 10.1111/bju.13072
Notes: Meeting Abstract#: 41 -- 68th Annual Scientific Meeting of the Urological-Society-of-Australia-and-New Zealand -- APR 11-14, 2015 -- Adelaide, AUSTRALIA -- 4 -- SI -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dana Elizabeth Rathkopf
    272 Rathkopf